UBC spinout Aspect inks deal with Novo Nordisk to develop 3-D printed diabetes-curing implants
Novo will pay Aspect US$75-million upfront to fund research and development and take an undisclosed stake in the startup
Source: theglobeandmail.com
Stay updated with breaking news from Simon Beyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novo will pay Aspect US$75-million upfront to fund research and development and take an undisclosed stake in the startup